Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European Stocks Higher; Optimism Over Brexit Talks Extension

Published 14/12/2020, 08:49
Updated 14/12/2020, 08:50
© Reuters

By Peter Nurse 

Investing.com - European stock markets traded higher Monday, adopting a cautiously optimistic stance after Brexit negotiations were extended past the Sunday deadline.

At 3:35 AM ET (0835 GMT), the DAX in Germany traded 0.8% higher, the CAC 40 in France rose 0.8%, and the U.K.'s FTSE index climbed 0.1%. 

U.K. Prime Minister Boris Johnson and European Commission President Ursula von der Leyen agreed over the weekend to go the “extra mile,” ignoring a self-imposed Sunday deadline and giving negotiators another shot at closing a trade deal. 

The talks looked doomed to failure at the end of last week, with Johnson stating that there was "a strong possibility" the two sides would fail to strike a trade deal. However, a weekend of intense diplomacy appears to have injected fresh momentum into the long-running process, increasing hopes a deal can be done this week.

At stake is around $1 trillion in annual trade at risk of facing tariffs and quotas if a deal cannot be reached before transition arrangements end on Dec. 31.

Elsewhere, the U.S. Food and Drug Administration granted authorization of the Pfizer/BioNTech Covid-19 vaccine late last week. The U.S. will see its first deliveries of the drug starting this week. 

There is also the possibility of additional fiscal stimulus in the U.S. with a bipartisan bill for a $908 billion Covid-19 relief package set to be introduced in Congress later in the day. 

On Sunday, German federal and state officials agree to put the country into a much tighter lockdown from Wednesday that will see the closure of non-essential stores as coronavirus cases surge during the winter period.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In corporate news, AstraZeneca (NASDAQ:AZN) stock dropped 5.9% after the pharma giant said over the weekend it would buy U.S. drugmaker Alexion Pharmaceuticals (NASDAQ:ALXN) for $39 billion in its largest ever deal. 

Eurozone industrial production data for October are due Monday, and are expected to show a rebound of 2.0% on the month, from a drop of 0.4% the previous month. 

Oil prices pushed higher Monday, continuing recent gains amid confidence the start of the rollout of the Covid-19 vaccine in the U.S., the world’s largest oil consumer, will result in a rebound in demand next year.

Jitters surrounding an oil tanker exploding after being hit by an as-yet unidentified external source while discharging at Jeddah port in Saudi Arabia also resulted in prices rising.

U.S. crude futures traded 1.3% higher at $47.15 a barrel, while the international benchmark Brent contract rose 1.2% to $50.55. Both benchmarks have posted gains for six consecutive weeks, their longest stretch since June.

Elsewhere, gold futures fell 0.7% to $1,830.25/oz, while EUR/USD traded 0.3% higher at 1.2144.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.